Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL2303 | 1.00 | — | — | |
| Formic Acid SCHEMBL83909 | 1.00 | — | — | |
| Formic Acid SCHEMBL1064783 | 1.00 | — | — | |
| Formic Acid SCHEMBL2511100 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| Formic Acid SCHEMBL1545886 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| Formic Acid SCHEMBL811681 | 1.00 | — | — | |
| Formic Acid SCHEMBL394887 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| Formic Acid SCHEMBL1545869 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| Formic Acid SCHEMBL18112628 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| Formic Acid SCHEMBL8503775 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9896422-B2 | Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits | Neumedics (US) | 2018-02-20 | — | — | US | disclosed |
| US-20170349554-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE | COGNITION THERAPEUTICS, INC. | 2017-12-07 | — | — | US | disclosed |
| US-9815770-B2 | Inhibitors of cognitive decline | COGNITION THERAPEUTICS, INC. (US) | 2017-11-14 | — | — | US | disclosed |
| EP-2670402-B1 | ISOLATED COMPOUNDS FROM TURMERIC OIL AND METHODS OF USE | COGNITION THERAPEUTICS INC (US) | 2017-09-20 | — | — | EP | disclosed |
| US-20170197977-A9 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE | COGNITION THERAPEUTICS, INC. (US) | 2017-07-13 | — | — | US | disclosed |
| US-20170144979-A1 | TETRACYCLINE DERIVATIVES WITH REDUCED ANTIBIOTIC ACTIVITY AND NEUROPROTECTIVE BENEFITS | Neumedics (US) | 2017-05-25 | — | — | US | disclosed |
| US-20170049723-A1 | ISOLATED COMPOUNDS FROM TURMERIC OIL AND METHODS OF USE | COGNITION THERAPEUTICS, INC. | 2017-02-23 | — | — | US | disclosed |
| US-9573912-B2 | Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits | Neumedics (US) | 2017-02-21 | — | — | US | disclosed |
| US-20160355458-A1 | INHIBITORS OF COGNITIVE DECLINE | COGNITION THERAPEUTICS, INC. | 2016-12-08 | — | — | US | disclosed |
| US-9499462-B2 | Isolated compounds from turmeric oil and methods of use | COGNITION THERAPEUTICS, INC. (US) | 2016-11-22 | — | — | US | disclosed |
| EP-2458983-A1 | INHIBITORS OF COGNITIVE DECLINE | Cognition Therapeutics, Inc. (US) | 2012-06-06 | — | — | EP | disclosed |
| US-20120129945-A1 | INHIBITORS OF COGNITIVE DECLINE | COGNITION THERAPEUTICS, INC. (US) | 2012-05-24 | — | — | US | disclosed |
| US-20120095105-A1 | INHIBITORS OF COGNITIVE DECLINE | COGNITION THERAPEUTICS, INC. (US) | 2012-04-19 | — | — | US | disclosed |
| EP-2416795-A1 | Inhibitors of cognitive decline | Cognition Therapeutics, Inc. (US) | 2012-02-15 | — | — | EP | disclosed |
| EP-2307027-A1 | TETRACYCLINE DERIVATIVES WITH REDUCED ANTIBIOTIC ACTIVITY AND NEUROPROTECTIVE BENEFITS | Neumedics (US) | 2011-04-13 | — | — | EP | disclosed |
| WO-2011014880-A1 | INHIBITORS OF COGNITIVE DECLINE | COGNITION THERAPEUTICS, INC. (US) | 2011-02-03 | — | — | WO | disclosed |
| WO-2010118055-A1 | INHIBITORS OF COGNITIVE DECLINE | COGNITION THERAPEUTICS, INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| US-20100087392-A1 | COMPLEXES OF IBUPROFEN, CYCLODEXTRINS AND TERNARY AGENTS AND THE USE THEREOF IN PHARMACEUTICS | PIERRE FABRE MEDICAMENT (FR) | 2010-04-08 | — | — | US | disclosed |
| WO-2010006292-A1 | TETRACYCLINE DERIVATIVES WITH REDUCED ANTIBIOTIC ACTIVITY AND NEUROPROTECTIVE BENEFITS | Neumedics (US) | 2010-01-14 | — | — | WO | disclosed |
| US-20090233910-A1 | Npy antagonists, preparation and uses | CEREP (FR) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349554-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE | TMEM97, SLC18A2, SIGMAR1 | ALDH1A1 4387/4885TSHR 2498/4885 |
| US-20120095105-A1 | INHIBITORS OF COGNITIVE DECLINE | PSEN2, ACHE, MAPT | ALDH1A1 3071/4885TSHR 4113/4885 |
| US-20090233910-A1 | Npy antagonists, preparation and uses | NPY1R, NPY5R, NPY2R | ALDH1A1 4542/4885TSHR 187/4885 |
| US-20120129945-A1 | INHIBITORS OF COGNITIVE DECLINE | PSEN2, ACHE, MAPT | ALDH1A1 3071/4885TSHR 4113/4885 |
| US-20160355458-A1 | INHIBITORS OF COGNITIVE DECLINE | PSEN2, ACHE, MAPT | ALDH1A1 3071/4885TSHR 4113/4885 |
| US-20170049723-A1 | ISOLATED COMPOUNDS FROM TURMERIC OIL AND METHODS OF USE | APP, MAPT, PSEN1 | ALDH1A1 3105/4885TSHR 4146/4885 |
| US-20170197977-A9 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE | TMEM97, SLC18A2, CHRNB2 | ALDH1A1 3240/4885TSHR 3559/4885 |
| US-20170144979-A1 | TETRACYCLINE DERIVATIVES WITH REDUCED ANTIBIOTIC ACTIVITY AND NEUROPROTECTIVE BENEFITS | DCX, CASP3, BCL2 | ALDH1A1 4504/4885TSHR 3726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.